| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $216K | +8.3K | +14.04% | $26.10 | 67.4K | May 24, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.13M | -8.3K | -12.31% | $136.40 | 59.1K | May 24, 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $33.9K | +1.3K | +2.2% | $26.10 | 60.4K | May 24, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$178K | -1.3K | -2.15% | $137.51 | 59.1K | May 24, 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $33.2K | +1.27K | +2.16% | $26.10 | 60.3K | May 24, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$176K | -1.27K | -2.11% | $138.61 | 59.1K | May 24, 2022 | Direct | F1, F2, F5 |
| holding | SGEN | Common Stock | 121K | May 24, 2022 | by Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8.3K | -76.34% | $0.00 | 2.57K | May 24, 2022 | Common Stock | 8.3K | $26.10 | Direct | F6 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.3K | -50.49% | $0.00 | 1.27K | May 24, 2022 | Common Stock | 1.3K | $26.10 | Direct | F6 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.27K | -100% | $0.00* | 0 | May 24, 2022 | Common Stock | 1.27K | $26.10 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $135.82 to $136.71. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $137.27 to $138.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $138.32 to $138.74. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |